Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px
Document › Details

MorphoSys AG. (5/3/23). "Press Release: MorphoSys AG Reports First Quarter 2023 Financial Results". Planegg.

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 Incyte Corporation (Nasdaq: INCY)
  Group Incyte Corporation (Group)
Products Product Minjuvi® / Monjuvi®
  Product 2 pelabresib (CPI-0610)
Persons Person Kress, Jean-Paul (MorphoSys 201909– CEO before Syntimmune + Biogen + Sanofi Genzyme)
  Person 2 Crabtree, Lucinda (MorphoSys 202307c– CFO before Autolus + Woodford Investment + Panmure Gordon + Goldman Sachs)

Record changed: 2023-10-21


Picture Berlin Partner Voices from HealthCapital Charpentier 650x200px

More documents for MorphoSys (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top